Hauguel-de Mouzon Sylvie, Lepercq Jacques, Catalano Patrick
Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH 44109, USA.
Am J Obstet Gynecol. 2006 Jun;194(6):1537-45. doi: 10.1016/j.ajog.2005.06.064. Epub 2006 Apr 21.
Leptin, which was identified originally as an adipocyte-derived protein, was regarded for years as an exclusive regulator of satiety and energy homeostasis. A role for leptin in pregnancy was later suggested by the findings that plasma levels during gestation are greater than in nongravid individuals and that leptin is synthesized within the fetoplacental unit. Observational studies have established that leptin production is dysregulated in several pathologic stages of pregnancy in association with alterations of fetal growth. For example, an overproduction of leptin by the placenta in pregnancy with diabetes mellitus or hypertension is associated with maternal hyperleptinemia. Evidence is also accumulating that umbilical leptin levels can be viewed as a biomarker of fetal adiposity. Ten years after its discovery as a hormone, we review the known and unknowns of leptin in pregnancy with particular emphasis on its functions in health and disease. We aim to demonstrate that studies of leptin in pregnancy largely have contributed to insight into the mechanisms of leptin action, both as a hormone and as a cytokine.
瘦素最初被鉴定为一种脂肪细胞衍生蛋白,多年来一直被视为饱腹感和能量稳态的唯一调节因子。后来,妊娠期间血浆水平高于非妊娠个体以及瘦素在胎儿 - 胎盘单位内合成的发现提示了瘦素在妊娠中的作用。观察性研究表明,在妊娠的几个病理阶段,瘦素的产生失调,与胎儿生长的改变有关。例如,患有糖尿病或高血压的孕妇胎盘过度产生瘦素与母体高瘦素血症有关。越来越多的证据表明,脐血瘦素水平可被视为胎儿肥胖的生物标志物。在瘦素作为一种激素被发现十年后,我们回顾了妊娠中瘦素的已知和未知情况,特别强调了其在健康和疾病中的功能。我们旨在证明,对妊娠中瘦素的研究在很大程度上有助于深入了解瘦素作为一种激素和细胞因子的作用机制。